Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022
Research

Targeted Screening for Chronic Q Fever, the Netherlands

Daphne F.M. ReukersComments to Author , Pieter T. de Boer, Alfons O. Loohuis, Peter C. Wever, Chantal P. Bleeker-Rovers, Arianne B. van Gageldonk-Lafeber, Wim van der Hoek, and Aura Timen
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (D.F.M. Reukers, P.T. de Boer, A.B. van Gageldonk-Lafeber, W. van der Hoek, A. Timen); Q-Support Foundation, ’s-Hertogenbosch, the Netherlands (A.O. Loohuis); Radboud University Medical Center, Nijmegen, the Netherlands (A.O. Loohuis, C.P. Bleeker-Rovers); Jeroen Bosch Hospital, ’s-Hertogenbosch (P.C. Wever); Vrije Universiteit, Amsterdam (A. Timen)

Main Article

Table 2

Results of a targeted screening program to detect chronic Q fever, the Netherlands*

GP practice† Province No. eligible patients‡ Study participants, no. (%) Seroprevalence (IgG II titer >1:64), no. (%) No. suspected of having chronic Q fever (IgG I titer >1:512)
1 NB 358 216 (60) 51 (24) 0
2 NB 250 108 (43) 18 (17) 0
3 NB 477 255 (53) 58 (23) 2
4 NB 267 160 (60) 48 (30) 2
5 NB 144 84 (58) 21 (25) 1
6 NB 381 183 (48) 22 (12) 1
7 NB 108 58 (54) 9 (16) 0
8 FR 124 40 (32) 11 (28) 0
9 LI 308 143 (46) 28 (20) 2
10 LI 376 147 (46) 4 (3) 0
11 LI 239 110 (46) 9 (8) 0
12 LI 134 53 (40) 2 (4) 1
13 UT 253 85 (34) 8 (9) 0
Total NA 3,419 1,642 (48) 289 (18) 9

*GP, general practitioner; FR, Friesland; LI, Limburg; NA, not applicable; NB, North-Brabant; UT, Utrecht. †Corresponding to numbers in [[ANCHOR###F1###Figure 1###Anchor]]. ‡Eligible patients are patients who had increased risk for development of chronic Q fever after infection with Coxiella burnetii (see [[ANCHOR###T1###Table 1###Anchor]] for specified inclusion criteria).

Main Article

Page created: May 06, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external